Related references
Note: Only part of the references are listed.Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer
Katharina Boehm et al.
WORLD JOURNAL OF UROLOGY (2017)
Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk
Pierre Lunardi et al.
WORLD JOURNAL OF UROLOGY (2017)
Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology
Jean-Pierre Droz et al.
EUROPEAN UROLOGY (2017)
Effect of Comorbidity on Prostate Cancer-Specific Mortality: A Prospective Observational Study
Prabhakar Rajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Primary Treatment Choice Over Time and Relative Survival of Prostate Cancer Patients: Influence of Age, Grade, and Stage
Katarina L. Matthes et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Support for the use of objective comorbidity indices in the assessment of noncancer death risk in prostate cancer patients
Sweet Ping Ng et al.
PROSTATE INTERNATIONAL (2017)
Causes of death in men with localized prostate cancer: a nationwide, population-based study
Mieke Van Hemelrijck et al.
BJU INTERNATIONAL (2016)
Association of Functional Status and Treatment Choice Among Older Men With Prostate Cancer in the Medicare Advantage Population
Bruce L. Jacobs et al.
CANCER (2016)
Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma
Oluwakayode Adejoro et al.
UROLOGY (2016)
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
C. Parker et al.
ANNALS OF ONCOLOGY (2015)
Predicting Life Expectancy in Men Diagnosed with Prostate Cancer
Jesse D. Sammon et al.
EUROPEAN UROLOGY (2015)
Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer
Ola Bratt et al.
EUROPEAN UROLOGY (2015)
Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study
Timothy J. Daskivich et al.
UROLOGY (2015)
Factors that influence patient preferences for prostate cancer management options: a systematic review
Timothy N. Showalter et al.
PATIENT PREFERENCE AND ADHERENCE (2015)
mice: Multivariate Imputation by Chained Equations inR
Stef van Buuren et al.
Journal of Statistical Software (2015)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Predictive mean matching imputation of semicontinuous variables
Gerko Vink et al.
STATISTICA NEERLANDICA (2014)
Charlson Comorbidity Index Is an Important Prognostic Factor for Long-Term Survival Outcomes in Korean Men with Prostate Cancer after Radical Prostatectomy
Joo Yong Lee et al.
YONSEI MEDICAL JOURNAL (2014)
Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population-Based Cohort of Men With Prostate Cancer
Timothy J. Daskivich et al.
ANNALS OF INTERNAL MEDICINE (2013)
Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study
M. de Camargo Cancela et al.
BRITISH JOURNAL OF CANCER (2013)
Impact of Age and Comorbidities on Long-term Survival of Patients with High-risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-institutional Competing-risks Analysis
Alberto Briganti et al.
EUROPEAN UROLOGY (2013)
Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients
Angela B. Mariotto et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Patterns and Correlates of Prostate Cancer Treatment in Older Men
Calpurnyia B. Roberts et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Imputation of missing values of tumour stage in population-based cancer registration
Nora Eisemann et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Overtreatment of Men With Low-Risk Prostate Cancer and Significant Comorbidity
Timothy J. Daskivich et al.
CANCER (2011)
Comorbidity and Competing Risks for Mortality in Men With Prostate Cancer
Timothy J. Daskivich et al.
CANCER (2011)
Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based Cohort
Firas Abdollah et al.
EUROPEAN UROLOGY (2011)
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Modelling relative survival in the presence of incomplete data: a tutorial
Ula Nur et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified
Nadine Grambauer et al.
STATISTICS IN MEDICINE (2010)
Simulating competing risks data in survival analysis
Jan Beyersmann et al.
STATISTICS IN MEDICINE (2009)
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy
Jochen Walz et al.
BJU INTERNATIONAL (2008)
What Improves with Increased Missing Data Imputations?
Todd E. Bodner
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL (2008)
A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards
Jan Beyersmann et al.
STATISTICS IN MEDICINE (2007)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Misspecified regression model for the subdistribution hazard of a competing risk
A. Latouche et al.
STATISTICS IN MEDICINE (2007)
Using the outcome for imputation of missing predictor values was preferred
Karel G. M. Moons et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Is there age bias in the treatment of localized prostate carcinoma?
SMH Alibhai et al.
CANCER (2004)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer
VV Kataja
ANNALS OF ONCOLOGY (2003)
Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data
JB Choudhury
STATISTICS IN MEDICINE (2002)
Factors associated with initial therapy for clinically localized prostate cancer: Prostate cancer outcomes study
LC Harlan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
